Algernon Pharmaceuticals Announces Receipt of CAD$2M Cash Refund from Australian Research Program and Files Application to List its Common Shares on Nasdaq Capital Market
Stock Information for Algernon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.